600079 人福医药
已收盘 07-25 15:00:00
资讯
新帖
简况
熊去氧胆酸概念盘中拉升,广生堂涨2.64%
市场透视 · 07-23
熊去氧胆酸概念盘中拉升,广生堂涨2.64%
人福医药(600079.SH):利斯的明透皮贴剂获得药品注册证书
智通财经 · 07-22
人福医药(600079.SH):利斯的明透皮贴剂获得药品注册证书
熊去氧胆酸概念盘中拉升,赛升药业涨4.95%
市场透视 · 07-22
熊去氧胆酸概念盘中拉升,赛升药业涨4.95%
研报掘金丨长城证券:予人福医药“买入”评级,创新药迈入产出期
格隆汇资讯 · 07-21
研报掘金丨长城证券:予人福医药“买入”评级,创新药迈入产出期
每周股票复盘:人福医药(600079)取消监事会并修订公司章程
证券之星 · 07-19
每周股票复盘:人福医药(600079)取消监事会并修订公司章程
人福医药获融资买入0.19亿元,近三日累计买入0.81亿元
金融界 · 07-19
人福医药获融资买入0.19亿元,近三日累计买入0.81亿元
人福医药:2025年第三次临时股东大会新增临时提案
公司公告 · 07-18
人福医药:2025年第三次临时股东大会新增临时提案
熊去氧胆酸概念盘中拉升,千红制药涨4.58%
市场透视 · 07-17
熊去氧胆酸概念盘中拉升,千红制药涨4.58%
抗癌概念盘中跳水,人福医药跌0.09%
市场透视 · 07-15
抗癌概念盘中跳水,人福医药跌0.09%
人福医药获得发明专利授权:“酰胺类化合物及其制备方法”
证券之星 · 07-14
人福医药获得发明专利授权:“酰胺类化合物及其制备方法”
人福医药:将于2025年7月30日召开2025年第三次临时股东会
公司公告 · 07-14
人福医药:将于2025年7月30日召开2025年第三次临时股东会
每周股票复盘:招商生科拟增持人福医药(600079)股份,比例1%-2%
证券之星 · 07-12
每周股票复盘:招商生科拟增持人福医药(600079)股份,比例1%-2%
人福医药:股东增加一致行动人
格隆汇 · 07-10
人福医药:股东增加一致行动人
【火热】青峰医药入局8亿潜力品种
米内网 · 07-10
【火热】青峰医药入局8亿潜力品种
熊去氧胆酸概念盘中拉升,上海医药涨3.00%
市场透视 · 07-10
熊去氧胆酸概念盘中拉升,上海医药涨3.00%
昊帆生物欲扩产,盯上人福医药“弃子”,IPO募投项目却龟速推进
投资有道杂志 · 07-09
昊帆生物欲扩产,盯上人福医药“弃子”,IPO募投项目却龟速推进
医药工业百强榜发布 人福医药位列19
人福医药 · 07-08
医药工业百强榜发布 人福医药位列19
中证报头版:A股投资价值稳步提升
中证报 · 07-06
中证报头版:A股投资价值稳步提升
湖北2024年新增5家上市公司 IPO募资额达33.9亿中部居首
长江商报 · 07-06
湖北2024年新增5家上市公司 IPO募资额达33.9亿中部居首
AI数字人揭晓湖北A股“成绩单”:2024年IPO募资居中部省份首位
湖北日报 · 07-04
AI数字人揭晓湖北A股“成绩单”:2024年IPO募资居中部省份首位
加载更多
公司概况
公司名称:
人福医药集团股份公司
所属行业:
医药制造业
上市日期:
1997-06-06
主营业务:
人福医药集团股份公司的主营业务是药品的研发、生产和销售。公司的主要产品是枸橼酸舒芬太尼注射液、注射用盐酸瑞芬太尼、盐酸氢吗啡酮注射液、盐酸纳布啡注射液、盐酸阿芬太尼注射液、注射用苯磺酸瑞马唑仑、米非司酮制剂、祖卡木颗粒、复方木尼孜其颗粒、注射用尿激酶、硫酸新霉素、黄体酮原料药。公司是湖北省医药工业龙头企业和国家技术创新示范企业。公司连续15年入选国家工信部“中国医药工业百强榜”,入选“2024中国制造业企业500强”、“2024中国制造业民营企业500强”榜单。
发行价格:
5.22
{"stockData":{"symbol":"600079","market":"SH","secType":"STK","nameCN":"人福医药","latestPrice":21.95,"timestamp":1753426800000,"preClose":22.2,"halted":0,"volume":16926249,"delay":0,"changeRate":-0.0113,"floatShares":1543000000,"shares":1632000000,"eps":0.8478,"marketStatus":"已收盘","change":-0.25,"latestTime":"07-25 15:00:00","open":22.25,"high":22.37,"low":21.9,"amount":374000000,"amplitude":0.0212,"askPrice":21.95,"askSize":120,"bidPrice":21.94,"bidSize":153,"shortable":0,"etf":0,"ttmEps":0.8478,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":22.2,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":24.42,"lowLimit":19.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1632225965,"isCdr":false,"pbRate":1.98,"roa":"--","peRate":25.89054,"roe":"3.02%","epsLYR":0.82,"committee":0.66155,"marketValue":35827000000,"turnoverRate":0.011,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-07-28。","floatMarketCap":33873000000},"requestUrl":"/m/hq/s/600079","defaultTab":"news","newsList":[{"id":"2553673892","title":"熊去氧胆酸概念盘中拉升,广生堂涨2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553673892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553673892?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:40","pubTimestamp":1753234812,"startTime":"0","endTime":"0","summary":"07月23日,熊去氧胆酸概念盘中拉升,截至09点40分,熊去氧胆酸概念整体指数上涨0.54%,报1352.250点。从个股上来看,该概念的成分股中,广生堂涨2.64%,上海医药、华润双鹤、人福医药涨幅居前。从资金上来看,截止发稿,熊去氧胆酸概念主力净流入为-4744.77万,其中千红制药受到资金热捧,主力净流入1282.67万;拉长时间线来看,该板块近20日主力资金净流入-19.15亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094012954dd1f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094012954dd1f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHPMY","601607","BK0012","BK0070","BK0188","BK0096","BK0239","BK0185","600079","02607","BK0028","300436"],"gpt_icon":0},{"id":"2553387512","title":"人福医药(600079.SH):利斯的明透皮贴剂获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2553387512","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553387512?lang=zh_cn&edition=full","pubTime":"2025-07-22 16:17","pubTimestamp":1753172274,"startTime":"0","endTime":"0","summary":"智通财经APP讯,人福医药(600079.SH)发布公告,公司控股子公司宜昌人福药业有限责任公司(简称“宜昌人福”,公司持有其80%的股权)近日收到国家药品监督管理局核准签发的利斯的明透皮贴剂的《药品注册证书》。本次利斯的明透皮贴剂获批,标志着公司具备了在国内市场销售该药品的资格。该产品进一步丰富了公司的产品线,其上市销售将给公司带来积极影响。宜昌人福将根据市场需求情况,着手安排利斯的明透皮贴剂的生产上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"人福医药(600079.SH):利斯的明透皮贴剂获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","600079","BK0239","BK0012","BK0070","BK0028","BK0096","BK0188"],"gpt_icon":0},{"id":"2553288112","title":"熊去氧胆酸概念盘中拉升,赛升药业涨4.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553288112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553288112?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:36","pubTimestamp":1753148213,"startTime":"0","endTime":"0","summary":"07月22日,熊去氧胆酸概念盘中拉升,截至09点36分,熊去氧胆酸概念整体指数上涨0.58%,报1363.650点。从个股上来看,该概念的成分股中,赛升药业涨4.95%,阿拉丁、宣泰医药、人福医药涨幅居前。从资金上来看,截止发稿,熊去氧胆酸概念主力净流入为-2606.95万,其中赛升药业受到资金热捧,主力净流入2371.84万;拉长时间线来看,该板块近20日主力资金净流入-13.50亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722093653a6b96a59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722093653a6b96a59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","688247","600079","BK0028","BK0096","BK0046","BK0012","300485","BK0239","BK0185","BK0188"],"gpt_icon":0},{"id":"2553240384","title":"研报掘金丨长城证券:予人福医药“买入”评级,创新药迈入产出期","url":"https://stock-news.laohu8.com/highlight/detail?id=2553240384","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553240384?lang=zh_cn&edition=full","pubTime":"2025-07-21 15:58","pubTimestamp":1753084708,"startTime":"0","endTime":"0","summary":"长城证券研报指出,人福医药加快一类创新药布局,涵盖化药、中药、生物制品三大类型,靶点聚焦肿瘤、镇痛、自身免疫等高价值领域。2024 年年报和公告显示,公司共有在研一类新药20项,已有9项进入临床Ⅱ期,其中重组质粒-肝细胞生长因子注射液静息痛适应症进入注册申报阶段,标志创新药迈入产出期。公司已建立以武汉、宜昌为核心的创新药平台体系,覆盖早研、临床与注册环节,平台化能力逐步完善。结合中期产品落地预期与业绩成长空间,预计公司2025–2027年归母净利润分别为23.09/25.97/29.13亿元,对应当前股价的PE分别为16/14/12倍,给予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072115583997ae59d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072115583997ae59d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002939","600079","159992"],"gpt_icon":0},{"id":"2552412035","title":"每周股票复盘:人福医药(600079)取消监事会并修订公司章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2552412035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552412035?lang=zh_cn&edition=full","pubTime":"2025-07-20 02:30","pubTimestamp":1752949831,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘,人福医药报收于22.15元,较上周的21.33元上涨3.84%。本周关注点公司公告汇总:人福医药取消监事会,监事会职权由董事会审计委员会行使。人福医药集团股份公司于2025年7月14日召开第十届董事会第八十一次会议,审议通过了《关于取消监事会暨修订〈公司章程〉的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000000569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0012","BK0185","BK0028","BK0070","BK0239","600079","BK0188"],"gpt_icon":0},{"id":"2552413898","title":"人福医药获融资买入0.19亿元,近三日累计买入0.81亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552413898","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552413898?lang=zh_cn&edition=full","pubTime":"2025-07-19 08:02","pubTimestamp":1752883350,"startTime":"0","endTime":"0","summary":"7月18日,沪深两融数据显示,人福医药获融资买入额0.19亿元,居两市第775位,当日融资偿还额0.20亿元,净卖出77.97万元。最近三个交易日,16日-18日,人福医药分别获融资买入0.31亿元、0.31亿元、0.19亿元。融券方面,当日融券卖出0.02万股,净买入0.58万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071908154695480f13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071908154695480f13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0028","BK0239","600079","BK0070","BK0188","BK0012","BK0185"],"gpt_icon":0},{"id":"2552499465","title":"人福医药:2025年第三次临时股东大会新增临时提案","url":"https://stock-news.laohu8.com/highlight/detail?id=2552499465","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552499465?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:40","pubTimestamp":1752828055,"startTime":"0","endTime":"0","summary":"人福医药公告,公司2025年第三次临时股东大会将增加《关于公司股东变更承诺的议案》作为临时提案,会议将于2025年7月30日召开,股权登记日为2025年7月22日。会议将审议包括修订公司章程、选举董事等多项议案,并涉及关联股东回避表决的情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718170213a45311a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718170213a45311a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0096","BK0185","600079","BK0188","BK0239","BK0028","BK0070"],"gpt_icon":0},{"id":"2552744571","title":"熊去氧胆酸概念盘中拉升,千红制药涨4.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552744571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552744571?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:00","pubTimestamp":1752717629,"startTime":"0","endTime":"0","summary":"07月17日,熊去氧胆酸概念盘中拉升,截至10点00分,熊去氧胆酸概念整体指数上涨1.04%,报1321.650点。从个股上来看,该概念的成分股中,千红制药涨4.58%,科伦药业、众生药业、人福医药涨幅居前。从资金上来看,截止发稿,熊去氧胆酸概念主力净流入为-1.00亿,其中科伦药业受到资金热捧,主力净流入3428.20万;拉长时间线来看,该板块近20日主力资金净流入-10.68亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717100029a6ae916b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717100029a6ae916b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0096","600079","002550","BK0028","BK0185","BK0239","BK0188","BK0012"],"gpt_icon":0},{"id":"2551137420","title":"抗癌概念盘中跳水,人福医药跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551137420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551137420?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:17","pubTimestamp":1752545857,"startTime":"0","endTime":"0","summary":"07月15日,抗癌概念盘中跳水,截至10点17分,抗癌概念整体指数下跌2.06%,报1104.390点。从个股上来看,该概念的成分股中,人福医药跌0.09%,信立泰、姚记科技跌幅居前。从资金上来看,截止发稿,抗癌概念主力净流入为-8.36亿,其中安科生物受到资金热捧,主力净流入6207.97万;拉长时间线来看,该板块近20日主力资金净流入-58.29亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507151017379542d6ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507151017379542d6ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0185","BK0028","BK0239","BK0188","BK0070","BK0012","600079"],"gpt_icon":0},{"id":"2551613363","title":"人福医药获得发明专利授权:“酰胺类化合物及其制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2551613363","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551613363?lang=zh_cn&edition=full","pubTime":"2025-07-15 02:38","pubTimestamp":1752518318,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示人福医药新获得一项发明专利授权,专利名为“酰胺类化合物及其制备方法”,专利申请号为CN202110799688.4,授权日为2025年7月15日。通过天眼查大数据分析,人福医药集团股份公司共对外投资了51家企业,参与招投标项目17次;财产线索方面有商标信息441条,专利信息258条,著作权信息7条;此外企业还拥有行政许可13个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071500001732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0239","BK0185","BK0096","600079","BK0188","BK0070"],"gpt_icon":0},{"id":"2551861188","title":"人福医药:将于2025年7月30日召开2025年第三次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2551861188","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551861188?lang=zh_cn&edition=full","pubTime":"2025-07-14 18:40","pubTimestamp":1752489645,"startTime":"0","endTime":"0","summary":"人福医药公告,公司董事会决定于2025年7月30日14点00分在武汉市 东湖高新 区高新大道666号召开第三次临时股东会,会议将采用现场投票与网络投票相结合的方式。会议将审议包括取消监事会暨修订《公司章程》、选举第十一届董事会董事等在内的11项议案,涉及非独立董事和独立董事的选举,并对中小投资者单独计票。参会股东需于2025年7月23日至29日完成登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714185011a449c52e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714185011a449c52e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0070","BK0188","BK0012","BK0185","BK0096","BK0239","600079"],"gpt_icon":0},{"id":"2551986916","title":"每周股票复盘:招商生科拟增持人福医药(600079)股份,比例1%-2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551986916","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551986916?lang=zh_cn&edition=full","pubTime":"2025-07-13 02:26","pubTimestamp":1752344770,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘,人福医药报收于21.33元,较上周的21.38元下跌0.23%。招商银行武汉分行拟为招商生科提供不超过人民币75,000万元的贷款支持,贷款期限36个月。股本股东变化招商生科与武汉高科签署《协议书》,达成一致行动关系,合计持有上市公司429,276,816股股份,占总股本26.30%。本次变动系招商生科和武汉高科结成一致行动人,各方持股比例未改变,未对公司现有股东结构及日常经营管理产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0070","BK0185","BK0239","BK0096","BK0012","600079"],"gpt_icon":0},{"id":"2550648443","title":"人福医药:股东增加一致行动人","url":"https://stock-news.laohu8.com/highlight/detail?id=2550648443","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550648443?lang=zh_cn&edition=full","pubTime":"2025-07-10 17:29","pubTimestamp":1752139771,"startTime":"0","endTime":"0","summary":"本次权益变动前,招商生科、生科投资发展、春泥1号原已合计控制人福医药403,089,608股股份、占公司总股本的24.70%对应的表决权,截至本报告披露日,因招商生科与武汉高科签署关于一致行动安排的《协议书》,合并计算招商生科、生科投资发展、春泥1号及一致行动人武汉高科持股比例由24.70%上升至26.30%。本次权益变动不触及控股股东和实际控制人发生变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071017295897a0c76f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071017295897a0c76f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0012","BK0185","BK0070","BK0028","BK0188","BK0239","600079"],"gpt_icon":0},{"id":"2550984612","title":"【火热】青峰医药入局8亿潜力品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2550984612","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550984612?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:31","pubTimestamp":1752136284,"startTime":"0","endTime":"0","summary":"精彩内容近日,青峰医药的富马酸伏诺拉生片以仿制4类报产获受理。今年以来,青峰医药有7个仿制药、1款1类新药首次报产/报临床。米内网数据显示,富马酸伏诺拉生片已被纳入国家医保乙类目录,原研产品近年来在中国三大终端六大市场的销售额均以两位数的增速持续增长,2024年突破8亿元,2025年第一季度以35%的增速继续增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164648a4422a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164648a4422a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","BK0239","600079","BK0188","BK0070","BK0185","BK0028","BK0012","BK0096","159938"],"gpt_icon":0},{"id":"2550698534","title":"熊去氧胆酸概念盘中拉升,上海医药涨3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550698534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550698534?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:44","pubTimestamp":1752111898,"startTime":"0","endTime":"0","summary":"07月10日,熊去氧胆酸概念盘中拉升,截至09点44分,熊去氧胆酸概念整体指数上涨0.50%,报1243.430点。从个股上来看,该概念的成分股中,上海医药涨3.00%,千红制药、人福医药、众生药业涨幅居前。从资金上来看,截止发稿,熊去氧胆酸概念主力净流入为-4135.38万,其中上海医药受到资金热捧,主力净流入2417.97万;拉长时间线来看,该板块近20日主力资金净流入-31.92亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094458a44165e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094458a44165e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0183","BK0070","BK0020","600079","BK0028","601607","BK0209","BK0096","BK0175","BK0184","BK0012","BK0099","BK0239","BK0097","BK0185","BK0187","BK0188"],"gpt_icon":0},{"id":"2550633938","title":"昊帆生物欲扩产,盯上人福医药“弃子”,IPO募投项目却龟速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2550633938","media":"投资有道杂志","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550633938?lang=zh_cn&edition=full","pubTime":"2025-07-09 17:17","pubTimestamp":1752052621,"startTime":"0","endTime":"0","summary":"昊帆生物正在计划收购下游客户以扩充产能。昊帆生物本次收购将分两期进行,第一期受让杭州福斯特85%股权,包括予君生物持有的52%股权和10名自然人持有的33%股权。2025年3月,昊帆生物官网公示安徽昊帆《年产1002吨多肽试剂及医药中间体建设项目竣工环境保护验收监测报告》。值得注意的是,昊帆生物的IPO保荐承销费率按照发行规模递增。而昊帆生物上市5个月后,股价开始长期破发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172046a440033f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172046a440033f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","600079","BK0028","BK0096","301393","BK0229","BK0188","BK0012","BK0239","BK0185"],"gpt_icon":0},{"id":"2549451908","title":"医药工业百强榜发布 人福医药位列19","url":"https://stock-news.laohu8.com/highlight/detail?id=2549451908","media":"人福医药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549451908?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:20","pubTimestamp":1751962839,"startTime":"0","endTime":"0","summary":"7月6日,以“探索生命 共创未来”为主题,由中国医药工业信息中心主办的第42届全国医药工业信息年会在北京市昌平区召开。会议期间发布了“2024年度中国医药工业主营业务收入前100位企业”,人福医药集团位列第19位。它源自《2024中国医药工业统计年报》的客观数据,由综合册中主营业务收入排序前100位的企业构成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708162927a43d99a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708162927a43d99a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0096","BK0185","BK0188","600079","BK0070","BK0239","BK0028"],"gpt_icon":0},{"id":"2549377402","title":"中证报头版:A股投资价值稳步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2549377402","media":"中证报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549377402?lang=zh_cn&edition=full","pubTime":"2025-07-07 07:55","pubTimestamp":1751846112,"startTime":"0","endTime":"0","summary":"据Wind统计,截至7月6日,股票回购增持再贷款设立以来,已有688家上市公司获银行股票回购增持贷款支持,贷款金额上限合计超1358.6亿元。今年以来,436家上市公司获银行股票回购增持贷款支持,贷款金额上限合计865.77亿元,新工具使用热度不减。除回购增持外,A股市场上分红频次增多,释放出上市公司回馈投资者、增强市场内在稳定性意识提升的积极信号。市场人士预计,相关部门有望继续加大政策支持力度,引导上市公司积极主动运用回购增持、一年多次分红等方式回馈投资者,助力提升上市公司投资价值,激活价值投资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707075438a43a805c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707075438a43a805c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["588050","588460","159982","588370","561550","588090","561950","BK0242","561300","561350","603259","000688","561000","560950","561990","600079","399300","600519","588060","563030","600157","000016","000001","560100","588080","000905"],"gpt_icon":0},{"id":"2549363371","title":"湖北2024年新增5家上市公司 IPO募资额达33.9亿中部居首","url":"https://stock-news.laohu8.com/highlight/detail?id=2549363371","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549363371?lang=zh_cn&edition=full","pubTime":"2025-07-07 06:24","pubTimestamp":1751840672,"startTime":"0","endTime":"0","summary":"报告显示,截至2024年末,湖北省A股上市公司数量达151家,总市值达1.46万亿元,数量和市值分别位居全国第10位和第13位。值得关注的是,湖北省2024年新增达梦数据、平安电工等5家上市公司,IPO募资33.9亿元,位居中部省份首位,新质生产力相关领域占比持续提升。2024年IPO募资额以33.9亿元位居中部首位,凸显资本市场对湖北企业的青睐。报告指出,2024年度全省151家A股上市公司合计披露研发支出达379亿元,连续三年呈增长趋势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707063535a43a669a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707063535a43a669a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600745","399300","BK0004","BK0139","BK0214","BK0070","600079","BK0090","BK0133","BK0113","BK0077","600498","688692","159982"],"gpt_icon":0},{"id":"2548393997","title":"AI数字人揭晓湖北A股“成绩单”:2024年IPO募资居中部省份首位","url":"https://stock-news.laohu8.com/highlight/detail?id=2548393997","media":"湖北日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548393997?lang=zh_cn&edition=full","pubTime":"2025-07-04 19:12","pubTimestamp":1751627573,"startTime":"0","endTime":"0","summary":"在中部地区,湖北“压舱石”地位稳固。报告显示,湖北省上市公司数量居中部省份第2位,2024年新增达梦数据、平安电工等5家上市公司,IPO募资33.9亿元,位居中部省份首位。2024年,湖北上市公司的创新动能持续增强。2024年湖北上市公司授权专利6786件,同比增长26.77%,重归高增长。长江产业集团负责人表示,上市公司是区域经济的压舱石,是产业升级的领头雁,是湖北加快建成中部地区崛起重要战略支点的核心力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704191610a436dacb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704191610a436dacb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","399300","BK0028","BK0070","BK0185","BK0239","BK0096","BK0012","600998","159982","600079"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753542283436,"stockEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":0.0457},{"period":"3month","weight":0.0845},{"period":"6month","weight":0.0027},{"period":"1year","weight":0.2089},{"period":"ytd","weight":-0.0612}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"人福医药集团股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49790人(较上一季度增加31.83%)","perCapita":"30993股","listingDate":"1997-06-06","address":"湖北省武汉市洪山区东湖高新区高新大道666号","registeredCapital":"163222万元","survey":" 人福医药集团股份公司的主营业务是药品的研发、生产和销售。公司的主要产品是枸橼酸舒芬太尼注射液、注射用盐酸瑞芬太尼、盐酸氢吗啡酮注射液、盐酸纳布啡注射液、盐酸阿芬太尼注射液、注射用苯磺酸瑞马唑仑、米非司酮制剂、祖卡木颗粒、复方木尼孜其颗粒、注射用尿激酶、硫酸新霉素、黄体酮原料药。公司是湖北省医药工业龙头企业和国家技术创新示范企业。公司连续15年入选国家工信部“中国医药工业百强榜”,入选“2024中国制造业企业500强”、“2024中国制造业民营企业500强”榜单。","listedPrice":5.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"人福医药,600079,人福医药股票,人福医药股票老虎,人福医药股票老虎国际,人福医药行情,人福医药股票行情,人福医药股价,人福医药股市,人福医药股票价格,人福医药股票交易,人福医药股票购买,人福医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}